ARDT — Ardent Health Inc. stock price, charts and financials

QT66Ardent Health Inc.

Ardent Health Inc. (NYSE: ARDT) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.08
-0.47-4.07%
OverviewShort InterestFilings
ARDTQT66Ardent Health Inc.·NYSE
11.08-4.07%
TA
Loading chart...
Signal & projected range
Earnings big miss — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
AGL+0.74%$96.22ASTH+3.43%$36.98HCSG-0.63%$22.09INNV-1.87%$10.97SNDA-2.31%$39.37AMN+1.08%$36.39PNTG+0.85%$39.33SGRY-2.06%$15.21
Snapshot
Index-P/E21.00EPS (ttm)0.55Insider Own2.54%Shs Outstand143.35MPerf Week8.25%
Market Cap1.66BForward P/E9.86EPS next Y1.17Insider Trans0.58%Shs Float22.34MPerf Month14.47%
Enterprise Value3.20BPEG-EPS next Q-Inst Own-Short Float3.22%Perf Quarter16.67%
Income79.14MP/S0.26EPS this Y7.33%Inst Trans-Short Ratio8.79Perf Half Y34.62%
Sales6.41BP/B1.21EPS next Y14.90%ROA1.48%Short Interest4.61MPerf YTD30.80%
Book/sh-P/C3.64EPS next 5Y9.55%ROE5.21%52W High14.85 -25.39%Perf Year2.21%
Cash/sh-P/FCF7.80EPS past 3/5Y-10.07% -ROIC9.26%52W Low7.40 49.81%Perf 3Y-
Dividend Est.-EV/EBITDA7.96Sales past 3/5Y7.22% -Gross Margin29.96%Volatility5.06% 4.87%Perf 5Y-
Dividend TTM-EV/Sales0.50EPS Y/Y TTM-39.87%Oper. Margin7.54%ATR (14)0.53Perf 10Y-
Dividend Ex-Date-Quick Ratio1.99Sales Y/Y TTM7.76%Profit Margin1.22%RSI (14)67.22Recom2.42
Dividend Gr. 3/5Y-Current Ratio2.10EPS Q/Q-3.45%SMA208.51%Beta1.12Target Price13.33
Payout0.00%Debt/Eq1.68Sales Q/Q7.01%SMA5016.00%Rel Volume0.61Prev Close11.55
Employees25,200LT Debt/Eq1.33EarningsNov 11SMA20017.76%Avg Volume559.26KPrice11.08
IPO DateJul 18, 2024Option/ShortYes / YesEPS/Sales Surpr.46.74% 1.53%Net Debt/EBITDA3.84Volume339,802Change-4.07%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-06-26ReiteratedGoldman Sachs$11 → $13
Aug-06-26ReiteratedGuggenheimBuy$14
Dec-18-25ReiteratedMizuhoOutperform$13 → $12
Dec-18-25ReiteratedUBSBuy$17 → $14
Nov-18-25ReiteratedMizuhoOutperform$20 → $13
Nov-17-25DowngradeKeybancOverweight → Sector Weight
Nov-14-25ReiteratedLeerink PartnersOutperform$23 → $16
Nov-14-25ReiteratedTruist SecuritiesBuy$22 → $13
Nov-14-25ReiteratedRBC CapitalOutperform$21 → $16
Nov-14-25DowngradeMorgan StanleyOverweight → Equal Weight$27 → $12
Latest News
Aug-07-26
Aug-07-2605:36AM
New Strong Sell Stocks for August 7thzacks.com
Aug-05-26
Aug-05-2605:05PM
Ardent Health Q2 Earnings Call Highlightsmarketbeat.com
04:30PM
Ardent Health, Inc. (ARDT) Q2 2026 Earnings Call Transcriptseekingalpha.com
03:43AM
First Trust Advisors LP Buys 198,595 Shares of Ardent Health, Inc. $ARDTdefenseworld.net
Aug-04-26
Aug-04-2608:02PM
Ardent Health, Inc. (ARDT) Q2 Earnings Lag Estimateszacks.com
04:17PM
Ardent Health Lowers FY2026 GAAP EPS Guidance from $0.90-$1.27 to $0.78-$1.15 vs $1.09 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.441B EstBenzinga
04:15PM
Ardent Health Reports Second Quarter 2026 Resultsbusinesswire.com
Jul-28-26
Jul-28-2611:06AM
Ardent Health, Inc. (ARDT) Expected to Beat Earnings Estimates: Should You Buy?zacks.com
Jul-23-26
Jul-23-2608:00AM
Kaskela Law Firm Announces Investigation of Ardent Health, Inc. (ARDT) and Encourages Long-Term ARDT Shareholders with Investment Losses to Contact the Firmgurufocus.com
08:00AM
Ardent Health surpasses 1 million patient encounters supported by ambient AIbusinesswire.com
Jul-17-26
Jul-17-2608:00AM
Ardent Health Announces Second Quarter 2026 Results Conference Call and Webcast Datebusinesswire.com
Jul-14-26
Jul-14-2609:25AM
Truist Securities Maintains Buy on Ardent Health, Lowers Price Target to $12Benzinga
Jul-09-26
Jul-09-2601:23PM
RBC Capital Maintains Outperform on Ardent Health, Lowers Price Target to $12Benzinga
Jun-29-26
Jun-29-2612:06PM
Do Options Traders Know Something About Ardent Health Stock We Don't?zacks.com
Company

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2018
12/31/2018
FY 2017
12/31/2017
FY 2016
12/31/2016
Total Revenue6,4066,3245,966——————
Cost of Goods Sold Incl. D&A4,4871561,033——————
Gross Profit1,9196,1694,933——————
Selling, General and Administrative Excl. Other1,0211,1933,885——————
Research and Development
000——————
Other Operating Expense4144,650642——————
Operating Income483326406——————
Interest Expense505566——————
Unusual Expense
—————————
Non-Operating Income (Expense)-2261623——————
Net Income Before Taxes208286363——————
Income Taxes405663——————
Consolidated Net Income79136210——————
Net Income From Continuing Operations168230300——————
Net Income79136210——————
EPS (Recurring)0.550.961.59——————
EPS (Basic, Before Extraordinaries)0.550.961.59——————
EPS (Diluted)0.550.961.58——————
EBITDA402497575——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio20.159.2010.81——————
Price To Sales Ratio0.250.200.38——————
Gross Margin29.9697.5582.69——————
Operating Margin7.545.156.81——————
Net Margin1.232.153.52——————
Shares Outstanding142141132——————
Market Capitalization1,5731,2452,255——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$16.32$13.92$11.52$9.12$6.72● Close Price0.00K46.60K93.20K139.80K186.40KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
LUMSDAINE ALFREDChief Financial OfficerJun 05 '26Buy8.8110,00088,100329,183Jun 08
DeMichiei RobertDirectorJun 05 '26Buy8.7311,26098,30035,564Jun 08
Webb Robert ThomasDirectorNov 08 '24Buy16.9820,000339,60040,275Nov 13
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.